Insulet (PODD) Divestments (2016)
Insulet (PODD) reported Divestments of $1.1 million for Q2 2016, down 76.16% quarter-over-quarter from $4.6 million in Q1 2016.
Insulet (PODD) Divestments (2016) Analysis & Trends
Insulet has reported Divestments for 1 years, with the latest figure at $1.1 million in Q2 2016.
- For the quarter ending Q2 2016, Divestments changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2017 stood at $1.1 million (down 76.16% YoY), and the FY2016 full-year result was $5.7 million, changed N/A from the prior year.
- Divestments for Q2 2016 stood at $1.1 million, down from $4.6 million in the prior quarter.
- The five-year high for Divestments was $4.6 million in Q1 2016, with the low at $1.1 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.37 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1.10 Mn |
| Mar 31, 2016 | 4.61 Mn |